← Every company
Eli Lilly and Co Lobbying
What Eli Lilly and Co discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
LLY on carbonthat →Disclosed spend
$8.3M
across every filing on file
Filings
25
Years covered
1
Firms retained
4
What it lobbies about
Health IssuesTrade (domestic/foreign)PharmacyMedicare/MedicaidBudget/AppropriationsTaxation/Internal Revenue Code
25 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20261st Quarter (Jan 1 - Mar 31) | ELI LILLY AND COMPANYTrade (domestic/foreign)Health Issues | $3.8M |
| 20262nd Quarter (Apr 1 - June 30) | ELI LILLY AND COMPANYCopyright/Patent/TrademarkMedicare/Medicaid | $3.3M |
| 20261st Quarter (Jan 1 - Mar 31) | CHECKMATE GOVERNMENT RELATIONSHealth IssuesTrade (domestic/foreign) | $120K |
| 20262nd Quarter (Apr 1 - June 30) | CHECKMATE GOVERNMENT RELATIONSHealth IssuesTrade (domestic/foreign) | $120K |
| 20261st Quarter (Jan 1 - Mar 31) | BROWNSTEIN HYATT FARBER SCHRECK, LLPPharmacyHealth Issues | $90K |
| 20261st Quarter (Jan 1 - Mar 31) | TODD STRATEGY GROUPHealth IssuesMedicare/Medicaid | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | TIBER CREEK GROUPMedicare/MedicaidHealth Issues | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | TIBER CREEK HEALTH STRATEGIES, INC. | $80K |
| 20262nd Quarter (Apr 1 - June 30) | TODD STRATEGY GROUPHealth IssuesMedicare/Medicaid | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | FEROX STRATEGIESPharmacy | $60K |
| 20262nd Quarter (Apr 1 - June 30) | MARSHALL & POPP, LLCPharmacyMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | TARPLIN, DOWNS & YOUNG, LLCHealth IssuesMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | MARSHALL & POPP, LLCMedicare/MedicaidPharmacy | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | GRV STRATEGIES LLCHealth IssuesTrade (domestic/foreign) | $60K |
| 20262nd Quarter (Apr 1 - June 30) | GRV STRATEGIES LLCHealth IssuesTrade (domestic/foreign) | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | VENN STRATEGIESHealth Issues | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | FORBES-TATEHealth IssuesMedicare/Medicaid | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | WILLIAMS AND JENSEN, PLLCTaxation/Internal Revenue CodeHealth Issues | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | MONUMENT ADVOCACYTrade (domestic/foreign)Foreign Relations | $40K |
| 20262nd Quarter (Apr 1 - June 30) | VENN STRATEGIESHealth Issues | $40K |
| 20261st Quarter (Jan 1 - Mar 31) | B HALL STRATEGIES, LLCPharmacy | $30K |
| 20262nd Quarter (Apr 1 - June 30) | B HALL STRATEGIES, LLCPharmacy | $30K |
| 20261st Quarter (Jan 1 - Mar 31) | THE HARPLE GROUP, LLCHealth Issues | $10K |
| 20262nd Quarter (Apr 1 - June 30) | THE HARPLE GROUP, LLCHealth Issues | $10K |
| 20261st Quarter (Jan 1 - Mar 31) | DLA PIPER LLP (US) | — |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on LLY
Company overviewEverything on LLY in one place, with the price.SEC filingsWhat LLY's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat LLY's own officers and directors buy and sell.Planned salesSales LLY insiders have filed notice of.Who owns itEvery manager reporting a position in LLY.Funds holding itWhich funds and ETFs hold LLY, and how big a bet.Who lobbies for itThe lobbyists on LLY's account, and who they worked for.Federal contractsWhat federal agencies pay LLY.PatentsWhat LLY is filing at the patent office.Workplace safetyWhat OSHA found at LLY's sites.